Aytu Biopharma AYTU
NASDAQ AYTU
$2.08 -0.01 (-0.48%)
As of: Oct 2, 2026 · 2:17 PM EDT

Aytu Biopharma (AYTU) Return on Assets [ROA] (2011 - 2026)

Updated

Aytu Biopharma's Return on Assets [ROA] came in at -13.15% for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 2.23 percentage points from -10.92% a year earlier but up 15.99 percentage points from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Return on Assets [ROA] was -12.44%, down 1.24 percentage points from FY2025.

  • Return on Assets [ROA] carries a five-year change of +15.39 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Assets [ROA] was -11.20% in FY2025 (+1.25 pp), -12.45% in FY2024 (-0.01 pp), -12.44% in FY2023 (+41.50 pp) and -53.95% in FY2022 (-26.12 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -70.99% (fiscal Q4 2022) to 1.36% (fiscal Q3 2025).
  • Year-over-year, Return on Assets [ROA] has declined for four consecutive quarters, with an average year-over-year change of -2.18 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q4 2023 (a gain of 58.97 percentage points), and the weakest in fiscal Q4 2022 (a drop of 49.39 percentage points).
  • Business Quant data shows AYTU's Return on Assets [ROA] at -29.15% (Q3 2026), -19.79% (Q2 2026) and -10.49% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Aytu Biopharma 23.25 Mn -92.42 Mn 10.41 Mn -13.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.15%
Mar 31, 2026 -29.15%
Dec 31, 2025 -19.79%
Sep 30, 2025 -10.49%
Jun 30, 2025 -10.92%
Mar 31, 2025 1.36%
Dec 31, 2024 -4.52%
Sep 30, 2024 -5.34%
Jun 30, 2024 -12.83%
Mar 31, 2024 -10.52%
Dec 31, 2023 -13.63%
Sep 30, 2023 -18.17%
Jun 30, 2023 -12.02%
Mar 31, 2023 -21.26%
Dec 31, 2022 -52.69%
Sep 30, 2022 -56.76%
Jun 30, 2022 -70.99%
Mar 31, 2022 -56.76%
Dec 31, 2021 -37.03%
Sep 30, 2021 -33.07%
API Access

Aytu Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEY